Effects of whole-body vibration exercise on functional capacity, muscle strength, and quality of life in individuals with severe chronic obstructive pulmonary disease: a systematic review and meta-analysis
Author: Beatriz Luiza Marinho Cunha1, Layane Santana P Costa1, Pedro Vinicius Porfírio2, Diego de Sousa Dantas1, Patrícia Erika de Melo Marinho1
Affiliation:
1 Post-graduation Program in Physical Therapy, Health Sciences Center, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
2 Undergraduation Course in Physical Therapy, Health Sciences Center, Universidade Federal de Pernambuco, Recife, Pernambuco, Brazil.
Conference/Journal: Physiother Theory Pract
Date published: 2024 Jul 2
Other:
Pages: 1-11 , Special Notes: doi: 10.1080/09593985.2024.2374053. , Word Count: 246
Background:
Whole body vibration (WBV) exercise is a therapy used for individuals with low tolerance to conventional exercises, such as patients with chronic obstructive pulmonary disease (COPD). This study aimed to assess the impact of WBV exercise on the functional capacity, muscle strength, and health-related quality of life (HRQoL) in severe COPD patients.
Methods:
Studies published until March 2024 were reviewed, encompassing randomized clinical trials (RCTs) without temporal or linguistic constraints, comparing WBV exercise with other interventions. The PubMed/MEDLINE, Scopus, Cochrane Airways Trials Register, and CINAHL databases were queried. The Revised Cochrane risk-of-bias tool for randomized trials 2.0A was employed for quality assessment.
Results:
Among 351 screened studies, 7 met the criteria, totaling 356 participants (WBV group, n = 182; control group, n = 174). Meta-analysis revealed a significant mean difference of 41.36 m [95%CI (13.28-69.44); p = .004] in the 6-minute walk test distance favoring the WBV group for functional capacity. Lower limb muscle strength improved in 57.14% of included studies. HRQoL meta-analysis demonstrated a 1.13-point difference [95%CI -1.24-3.51; p = .35] favoring WBV, although group differences were not significant. A mean difference of 2.31 points favored the control group in health condition [95%CI (-1.32-5.94); p = .021].
Conclusion:
WBV exercise is recognized as a promising therapeutic modality for severe COPD patients, notably enhancing functional capacity. Although heterogeneous study protocols weaken the evidence for clinically relevant outcomes, improvements in lower limb muscle strength and HRQoL were also observed, differences between groups were not significant.
Keywords: Chronic obstructive pulmonary disease; dyspnea; exercise tolerance; muscle strength; quality of life.
PMID: 38953511 DOI: 10.1080/09593985.2024.2374053
BACK
